Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 17 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Link between measles virus and gut abnormalities in children with developmental disorder

Measles virus may link a new form of inflammatory bowel disease (IBD) and developmental disorder, suggests a study in Journal of Clinical Pathology - Molecular Pathology, to be published in the spring, but released immediately in full on the Internet.

News image

fiogf49gjkf04

The authors (from Dublin, Ireland and London, England) conclude that the virus may act as an immunologic trigger. It was found in the intestinal biopsies of 75 out of 91 children with the variant form of bowel disease (ileocolonic lymphonodular hyperplasia), but in only 5 out of 70 healthy children.

It was found that more boys than girls were affected.

The study does not report whether the children were vaccinated with the triple mumps measles and rubella (MMR) vaccine.

An accompanying editorial advises against jumping to any hasty conclusions about MMR causing either the bowel disease or the developmental disorder, or it being responsible for all cases of autism and/or IBD.

The editorial concludes that there is evidence that developmental disorders are associated with some disturbance in the interaction between the brain and the gut, and that the study findings warrant attention.

Proportion with measles virus:
Bowel disorder: 82%
Controls: 7%
Journal of Clinical Pathology - Molecular Pathology

However, the authors say that several critical questions need to be answered before any potential link with MMR can be proved. These include whether the measles virus was the same strain as that used in the vaccine.

In a statement issued today, Professor John O'Leary, molecular pathologist at Coombe Women's Hospital, Dublin, Ireland, and lead author of the study, comments, "I stand by the findings of our research, which raises many questions about whether measles virus has a role in bowel inflammation in developmental disorder.

"The research did not set out to investigate the role of MMR in the development of either bowel disease or developmental disorder, and no conclusions about such a role could, or should be, drawn from our findings."

The editors of Molecular Pathology, Professor John Crocker and Dr David Burnett, add, "This paper was submitted by a scientist of international reputation, and accepted for publication after peer review.

"It was recognized by the referees and the editors as a potentially important observation which raised many questions about the possible role of measles in the etiology of a syndrome in children.

"The paper did not set out to investigate the role of MMR in developmental disorders or bowel disease, and no role for MMR is suggested in it."

"But we did accept that some readers might jump to the conclusion that this paper does in some way link MMR to behavioral disorders," they said.

"We therefore commissioned a commentary by a member of our editorial board.

"That commentary reinforces our view that this research is an important piece of work that draws conclusions entirely consistent with the data, but that any link with MMR is not justified, and was not intended by the study authors," they concluded.

J Clin Pathol-Mol Pa 2002; 55: 1-6
06 February 2002

Go to top of page Email this page Email this page to a colleague

 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 20 December 2017 
Management of abnormal liver blood tests
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Tryptophan metabolism and IBD activity
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy
 12 December 2017 
High-risk colorectal cancer patients
 06 December 2017 
Reflux-induced chronic cough 
 06 December 2017 
Systemic inflammatory response syndrome in acute-on-chronic liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us